Literature DB >> 31911633

Rare germline variant contributions to myeloid malignancy susceptibility.

Samuel T Li1, Janet Wang1, Ruipeng Wei1, Ruqi Shi1, Vera Adema2, Yasunobu Nagata2, Cassandra M Kerr2, Teodora Kuzmanovic2, Bartlomiej Przychodzen2, Francesc Sole3, Jaroslaw P Maciejewski2, Thomas LaFramboise4.   

Abstract

Entities:  

Mesh:

Year:  2020        PMID: 31911633      PMCID: PMC8908771          DOI: 10.1038/s41375-019-0701-8

Source DB:  PubMed          Journal:  Leukemia        ISSN: 0887-6924            Impact factor:   11.528


× No keyword cloud information.
  15 in total

1.  Germline ETV6 mutations in familial thrombocytopenia and hematologic malignancy.

Authors:  Michael Y Zhang; Jane E Churpek; Siobán B Keel; Tom Walsh; Ming K Lee; Keith R Loeb; Suleyman Gulsuner; Colin C Pritchard; Marilyn Sanchez-Bonilla; Jeffrey J Delrow; Ryan S Basom; Melissa Forouhar; Boglarka Gyurkocza; Bradford S Schwartz; Barbara Neistadt; Rafael Marquez; Christopher J Mariani; Scott A Coats; Inga Hofmann; R Coleman Lindsley; David A Williams; Janis L Abkowitz; Marshall S Horwitz; Mary-Claire King; Lucy A Godley; Akiko Shimamura
Journal:  Nat Genet       Date:  2015-01-12       Impact factor: 38.330

2.  In vitro analyses of known and novel RUNX1/AML1 mutations in dominant familial platelet disorder with predisposition to acute myelogenous leukemia: implications for mechanisms of pathogenesis.

Authors:  Joëlle Michaud; Feng Wu; Motomi Osato; Gregory M Cottles; Masatoshi Yanagida; Norio Asou; Katsuya Shigesada; Yoshiaki Ito; Kathleen F Benson; Wendy H Raskind; Colette Rossier; Stylianos E Antonarakis; Sara Israels; Archie McNicol; Harvey Weiss; Marshall Horwitz; Hamish S Scott
Journal:  Blood       Date:  2002-02-15       Impact factor: 22.113

3.  Genetic characterization of myeloperoxidase deficiency in Italy.

Authors:  Caterina Marchetti; Pierluigi Patriarca; G Pietro Solero; Francisco E Baralle; Maurizio Romano
Journal:  Hum Mutat       Date:  2004-05       Impact factor: 4.878

Review 4.  The 2016 revision to the World Health Organization classification of myeloid neoplasms and acute leukemia.

Authors:  Daniel A Arber; Attilio Orazi; Robert Hasserjian; Jürgen Thiele; Michael J Borowitz; Michelle M Le Beau; Clara D Bloomfield; Mario Cazzola; James W Vardiman
Journal:  Blood       Date:  2016-04-11       Impact factor: 22.113

5.  Human genomics. The Genotype-Tissue Expression (GTEx) pilot analysis: multitissue gene regulation in humans.

Authors: 
Journal:  Science       Date:  2015-05-07       Impact factor: 47.728

6.  Genomic analysis of germ line and somatic variants in familial myelodysplasia/acute myeloid leukemia.

Authors:  Jane E Churpek; Khateriaa Pyrtel; Krishna-Latha Kanchi; Jin Shao; Daniel Koboldt; Christopher A Miller; Dong Shen; Robert Fulton; Michelle O'Laughlin; Catrina Fronick; Iskra Pusic; Geoffrey L Uy; Evan M Braunstein; Mark Levis; Julie Ross; Kevin Elliott; Sharon Heath; Allan Jiang; Peter Westervelt; John F DiPersio; Daniel C Link; Matthew J Walter; John Welch; Richard Wilson; Timothy J Ley; Lucy A Godley; Timothy A Graubert
Journal:  Blood       Date:  2015-10-22       Impact factor: 22.113

7.  Inherited and Somatic Defects in DDX41 in Myeloid Neoplasms.

Authors:  Chantana Polprasert; Isabell Schulze; Mikkael A Sekeres; Hideki Makishima; Bartlomiej Przychodzen; Naoko Hosono; Jarnail Singh; Richard A Padgett; Xiaorong Gu; James G Phillips; Michael Clemente; Yvonne Parker; Daniel Lindner; Brittney Dienes; Eckhard Jankowsky; Yogen Saunthararajah; Yang Du; Kevin Oakley; Nhu Nguyen; Sudipto Mukherjee; Caroline Pabst; Lucy A Godley; Jane E Churpek; Daniel A Pollyea; Utz Krug; Wolfgang E Berdel; Hans-Ulrich Klein; Martin Dugas; Yuichi Shiraishi; Kenichi Chiba; Hiroko Tanaka; Satoru Miyano; Kenichi Yoshida; Seishi Ogawa; Carsten Müller-Tidow; Jaroslaw P Maciejewski
Journal:  Cancer Cell       Date:  2015-04-23       Impact factor: 31.743

8.  The Allelic Landscape of Human Blood Cell Trait Variation and Links to Common Complex Disease.

Authors:  William J Astle; Heather Elding; Tao Jiang; Dave Allen; Dace Ruklisa; Alice L Mann; Daniel Mead; Heleen Bouman; Fernando Riveros-Mckay; Myrto A Kostadima; John J Lambourne; Suthesh Sivapalaratnam; Kate Downes; Kousik Kundu; Lorenzo Bomba; Kim Berentsen; John R Bradley; Louise C Daugherty; Olivier Delaneau; Kathleen Freson; Stephen F Garner; Luigi Grassi; Jose Guerrero; Matthias Haimel; Eva M Janssen-Megens; Anita Kaan; Mihir Kamat; Bowon Kim; Amit Mandoli; Jonathan Marchini; Joost H A Martens; Stuart Meacham; Karyn Megy; Jared O'Connell; Romina Petersen; Nilofar Sharifi; Simon M Sheard; James R Staley; Salih Tuna; Martijn van der Ent; Klaudia Walter; Shuang-Yin Wang; Eleanor Wheeler; Steven P Wilder; Valentina Iotchkova; Carmel Moore; Jennifer Sambrook; Hendrik G Stunnenberg; Emanuele Di Angelantonio; Stephen Kaptoge; Taco W Kuijpers; Enrique Carrillo-de-Santa-Pau; David Juan; Daniel Rico; Alfonso Valencia; Lu Chen; Bing Ge; Louella Vasquez; Tony Kwan; Diego Garrido-Martín; Stephen Watt; Ying Yang; Roderic Guigo; Stephan Beck; Dirk S Paul; Tomi Pastinen; David Bujold; Guillaume Bourque; Mattia Frontini; John Danesh; David J Roberts; Willem H Ouwehand; Adam S Butterworth; Nicole Soranzo
Journal:  Cell       Date:  2016-11-17       Impact factor: 41.582

9.  Clinical utility of gene panel-based testing for hereditary myelodysplastic syndrome/acute leukemia predisposition syndromes.

Authors:  L Guidugli; A K Johnson; G Alkorta-Aranburu; V Nelakuditi; K Arndt; J E Churpek; L A Godley; D Townsley; N S Young; C Fitzpatrick; D Del Gaudio; S Das; Z Li
Journal:  Leukemia       Date:  2017-01-20       Impact factor: 11.528

10.  Functional genomic landscape of acute myeloid leukaemia.

Authors:  Jeffrey W Tyner; Cristina E Tognon; Daniel Bottomly; Beth Wilmot; Stephen E Kurtz; Samantha L Savage; Nicola Long; Anna Reister Schultz; Elie Traer; Melissa Abel; Anupriya Agarwal; Aurora Blucher; Uma Borate; Jade Bryant; Russell Burke; Amy Carlos; Richie Carpenter; Joseph Carroll; Bill H Chang; Cody Coblentz; Amanda d'Almeida; Rachel Cook; Alexey Danilov; Kim-Hien T Dao; Michie Degnin; Deirdre Devine; James Dibb; David K Edwards; Christopher A Eide; Isabel English; Jason Glover; Rachel Henson; Hibery Ho; Abdusebur Jemal; Kara Johnson; Ryan Johnson; Brian Junio; Andy Kaempf; Jessica Leonard; Chenwei Lin; Selina Qiuying Liu; Pierrette Lo; Marc M Loriaux; Samuel Luty; Tara Macey; Jason MacManiman; Jacqueline Martinez; Motomi Mori; Dylan Nelson; Ceilidh Nichols; Jill Peters; Justin Ramsdill; Angela Rofelty; Robert Schuff; Robert Searles; Erik Segerdell; Rebecca L Smith; Stephen E Spurgeon; Tyler Sweeney; Aashis Thapa; Corinne Visser; Jake Wagner; Kevin Watanabe-Smith; Kristen Werth; Joelle Wolf; Libbey White; Amy Yates; Haijiao Zhang; Christopher R Cogle; Robert H Collins; Denise C Connolly; Michael W Deininger; Leylah Drusbosky; Christopher S Hourigan; Craig T Jordan; Patricia Kropf; Tara L Lin; Micaela E Martinez; Bruno C Medeiros; Rachel R Pallapati; Daniel A Pollyea; Ronan T Swords; Justin M Watts; Scott J Weir; David L Wiest; Ryan M Winters; Shannon K McWeeney; Brian J Druker
Journal:  Nature       Date:  2018-10-17       Impact factor: 49.962

View more
  2 in total

1.  Rare germline alterations of myeloperoxidase predispose to myeloid neoplasms.

Authors:  Sunisa Kongkiatkamon; Laila Terkawi; Yihong Guan; Vera Adema; Metis Hasipek; Tatiana Dombrovski; Milo Co; Wencke Walter; Hassan Awada; Yvonne Parker; Stephan Hutter; Simona Pagliuca; Carmelo Gurnari; Heesun J Rogers; Manja Meggendorfer; Daniel J Lindner; Torsten Haferlach; Valeria Visconte; Thomas LaFramboise; Babal K Jha; Jaroslaw P Maciejewski
Journal:  Leukemia       Date:  2022-06-27       Impact factor: 12.883

Review 2.  Comparison of Laboratory Methods for the Clinical Follow Up of Checkpoint Blockade Therapies in Leukemia: Current Status and Challenges Ahead.

Authors:  Basak Aru; Mojdeh Soltani; Cemil Pehlivanoglu; Ege Gürlü; Mazdak Ganjalikhani-Hakemi; Gülderen Yanikkaya Demirel
Journal:  Front Oncol       Date:  2022-01-27       Impact factor: 6.244

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.